Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124412 | SCV000167845 | benign | not specified | 2014-06-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000313108 | SCV000425534 | benign | Ehlers-Danlos syndrome, type 4 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV000313108 | SCV000631652 | likely benign | Ehlers-Danlos syndrome, type 4 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000777801 | SCV000738543 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000659423 | SCV000781237 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755958 | SCV000883643 | likely benign | not provided | 2017-07-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777801 | SCV000913793 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000124412 | SCV001372394 | benign | not specified | 2020-06-29 | criteria provided, single submitter | clinical testing | Variant summary: COL3A1 c.2805T>C alters a non-conserved nucleotide resulting in a synonymous change. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00012 in 250242 control chromosomes (gnomAD). The observed variant frequency is approximately 93 fold of the estimated maximal expected allele frequency for a pathogenic variant in COL3A1 causing Aortopathy phenotype (1.3e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.2805T>C in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. Six ClinVar submitters (evaluation after 2014) cite the variant as benign (2x) and likely benign (4x). Based on the evidence outlined above, the variant was classified as benign. |
Ce |
RCV000755958 | SCV001501791 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | COL3A1: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV002277193 | SCV002565628 | uncertain significance | Ehlers-Danlos syndrome | 2020-03-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000313108 | SCV004826028 | benign | Ehlers-Danlos syndrome, type 4 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530078 | SCV004714826 | likely benign | COL3A1-related disorder | 2022-08-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |